BAP1 promotes osteoclast function by metabolic reprogramming

Treatment of osteoporosis commonly diminishes osteoclast number which suppresses bone formation thus compromising fracture prevention. Bone formation is not suppressed, however, when bone degradation is reduced by retarding osteoclast functional resorptive capacity, rather than differentiation. We f...

Descripción completa

Detalles Bibliográficos
Autores principales: Rohatgi, Nidhi, Zou, Wei, Li, Yongjia, Cho, Kevin, Collins, Patrick L., Tycksen, Eric, Pandey, Gaurav, DeSelm, Carl J., Patti, Gary J., Dey, Anwesha, Teitelbaum, Steven L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516877/
https://www.ncbi.nlm.nih.gov/pubmed/37740028
http://dx.doi.org/10.1038/s41467-023-41629-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516877/
https://www.ncbi.nlm.nih.gov/pubmed/37740028
http://dx.doi.org/10.1038/s41467-023-41629-4

Ejemplares similares